{"id":"https://openalex.org/W4412908879","doi":"https://doi.org/10.1159/000547431","title":"Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy","display_name":"Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy","publication_year":2025,"publication_date":"2025-07-25","ids":{"openalex":"https://openalex.org/W4412908879","doi":"https://doi.org/10.1159/000547431","pmid":"https://pubmed.ncbi.nlm.nih.gov/41063863","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12503597"},"language":"en","primary_location":{"id":"doi:10.1159/000547431","doi":"https://doi.org/10.1159/000547431","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000547431","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1159/000547431","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Cristina-Maria Florea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149159","display_name":"H\u00f4pital de Sion","ror":"https://ror.org/055awd420","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210149159"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Cristina-Maria Florea","raw_affiliation_strings":["Department of Medical Oncology, Sion Hospital, Sion, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sion Hospital, Sion, Switzerland","institution_ids":["https://openalex.org/I4210149159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102744602","display_name":"Laurent Parmentier","orcid":"https://orcid.org/0000-0003-1455-0620","observed_orcids":["https://orcid.org/0000-0003-1455-0620"]},"institutions":[{"id":"https://openalex.org/I4210149159","display_name":"H\u00f4pital de Sion","ror":"https://ror.org/055awd420","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210149159"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Laurent Parmentier","raw_affiliation_strings":["Department of Dermatology, Sion Hospital, Sion, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Sion Hospital, Sion, Switzerland","institution_ids":["https://openalex.org/I4210149159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101257743","display_name":"Mohamed H. Abdou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149159","display_name":"H\u00f4pital de Sion","ror":"https://ror.org/055awd420","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210149159"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mohamed Abdou","raw_affiliation_strings":["Department of Dermatology, Sion Hospital, Sion, Switzerland","Department of Pathology, Central Institute - Sion Hospital, Sion, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Sion Hospital, Sion, Switzerland","institution_ids":["https://openalex.org/I4210149159"]},{"raw_affiliation_string":"Department of Pathology, Central Institute - Sion Hospital, Sion, Switzerland","institution_ids":["https://openalex.org/I4210149159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046496560","display_name":"Gr\u00e9goire Berthod","orcid":"https://orcid.org/0009-0002-8893-5240","observed_orcids":["https://orcid.org/0009-0002-8893-5240"]},"institutions":[{"id":"https://openalex.org/I4210149159","display_name":"H\u00f4pital de Sion","ror":"https://ror.org/055awd420","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210149159"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gr\u00e9goire Berthod","raw_affiliation_strings":["Department of Medical Oncology, Sion Hospital, Sion, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sion Hospital, Sion, Switzerland","institution_ids":["https://openalex.org/I4210149159"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210149159"],"apc_list":{"value":1170,"currency":"USD","value_usd":1170},"apc_paid":{"value":1170,"currency":"USD","value_usd":1170},"fwci":1.8426,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.84947432,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"18","issue":"1","first_page":"1171","last_page":"1177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8467000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8467000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":0.1509000062942505,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/bullous-pemphigoid","display_name":"bullous pemphigoid","score":0.9589999914169312},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9580000042915344},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9629999995231628},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/immunotherapy-rechallenge","display_name":"immunotherapy rechallenge","score":0.7639999985694885},{"id":"https://openalex.org/keywords/steroid-sparing-therapy","display_name":"steroid-sparing therapy","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.9594460725784302},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9338705539703369},{"id":"https://openalex.org/C2779252107","wikidata":"https://www.wikidata.org/wiki/Q1004647","display_name":"Bullous pemphigoid","level":3,"score":0.7878276109695435},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6948876976966858},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6812721490859985},{"id":"https://openalex.org/C2778075117","wikidata":"https://www.wikidata.org/wiki/Q881811","display_name":"Pemphigoid","level":4,"score":0.5646122097969055},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30076104402542114},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.16986435651779175},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.15429523587226868},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.09271013736724854}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1159/000547431","doi":"https://doi.org/10.1159/000547431","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000547431","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12503597","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12503597/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12503597/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Rep Oncol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:11311480","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12503597","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41063863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41063863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case reports in oncology","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:3a82c4e11e9d431d9297977432e1abda","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/3a82c4e11e9d431d9297977432e1abda","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Case Reports in Oncology, Vol 18, Iss 1, Pp 1179-1185 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1159/000547431","doi":"https://doi.org/10.1159/000547431","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000547431","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412908879.pdf","grobid_xml":"https://content.openalex.org/works/W4412908879.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2776592021","https://openalex.org/W2955748916","https://openalex.org/W3011657961","https://openalex.org/W3192166808","https://openalex.org/W3210960512","https://openalex.org/W4206187073","https://openalex.org/W4379259440","https://openalex.org/W4385067277","https://openalex.org/W4391989203","https://openalex.org/W4392448313","https://openalex.org/W4401194817","https://openalex.org/W4401634651","https://openalex.org/W4402194497"],"related_works":["https://openalex.org/W4414520986","https://openalex.org/W4410803490","https://openalex.org/W4412196711","https://openalex.org/W4399122647","https://openalex.org/W7161963620","https://openalex.org/W7147293818","https://openalex.org/W3092136344","https://openalex.org/W4407565485","https://openalex.org/W4368356900","https://openalex.org/W4410874888"],"abstract_inverted_index":{"Introduction:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICIs)":[4],"represent":[5],"a":[6,20,45,50,68,98,117,125],"new":[7],"class":[8],"of":[9,44,74,84],"antitumor":[10],"agents":[11],"in":[12,49,115],"oncology.":[13],"Their":[14],"use":[15],"has":[16],"been":[17],"associated":[18],"with":[19,30,55,119],"specific":[21],"safety":[22],"profile,":[23],"known":[24],"as":[25,67],"immune-related":[26],"adverse":[27],"events":[28],"(irAEs),":[29],"dermatological":[31,87],"toxicities":[32],"being":[33],"the":[34,42,72,82,90,112],"most":[35],"frequently":[36],"encountered.":[37],"Case":[38],"Report:":[39],"We":[40],"report":[41],"case":[43,80,110],"bullous":[46],"pemphigoid":[47],"(BP)":[48],"metastatic":[51],"melanoma":[52],"patient,":[53],"treated":[54],"ipilimumab":[56],"and":[57,89],"nivolumab.":[58],"This":[59,79],"immune-mediated":[60],"toxicity":[61],"was":[62,122],"controlled":[63],"by":[64],"using":[65],"dupilumab":[66,126],"steroid-sparing":[69],"therapy,":[70],"allowing":[71],"reintroduction":[73],"immunotherapy":[75],"without":[76],"relapse.":[77],"Conclusion:":[78],"illustrates":[81],"complexity":[83],"managing":[85],"some":[86],"irAEs":[88],"need":[91],"for":[92,101,128],"better":[93],"treatment":[94,127],"strategies.":[95],"Dupilumab":[96],"is":[97,111],"promising":[99],"agent":[100],"cutaneous":[102],"irAEs,":[103],"including":[104],"ICI-BP.":[105,130],"To":[106],"our":[107,109],"knowledge,":[108],"first":[113],"one":[114],"which":[116],"rechallenge":[118],"an":[120,129],"ICI":[121],"attempted":[123],"after":[124]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2025-08-04T00:00:00"}